INHIBRX BIOSCIENCES INC (INBX) — institutional ownership
176 funds reported holding INHIBRX BIOSCIENCES INC in their latest 13F filings, worth $1.45B in total (CUSIP 45720N103).
Largest holders
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $124M
- PERCEPTIVE ADVISORS LLC — $123M
- Sanofi (SNY, SNYNF) — $110M
- VIKING GLOBAL INVESTORS LP — $106M
- HighTower Advisors, LLC — $82.5M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $79.7M
- BlackRock, Inc. (BLK) — $78.3M
- Schonfeld Strategic Advisors LLC — $66.1M
- STATE STREET CORP (STT, STT-PG) — $60.7M
- VANGUARD GROUP INC — $49.2M
Famous investors holding it
- Andreas Halvorsen portfolio (Viking Global Investors)
- Izzy Englander portfolio (Millennium Management)
- Renaissance Technologies portfolio (Renaissance Technologies)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Ken Griffin portfolio (Citadel Advisors)
Insider buying and selling at INHIBRX BIOSCIENCES INC
Who owns the most INBX stock?
The largest institutional holders in the latest 13F filings are MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) ($124M), PERCEPTIVE ADVISORS LLC ($123M), Sanofi (SNY, SNYNF) ($110M).
How many funds own INBX?
176 funds reported holding it, worth $1.45B in total.